Prehabilitation–How to Make Surgery Safer
Presented by Luke Burchill MBBS PhD
Dr. Luke J Burchill MBBS PhD is an Assistant Professor of Medicine and Cardiologist in the Adult Congenital Heart Disease Program at the Knight Cardiovascular Research Institute, Oregon Health Science University (Portland, Oregon, USA). He received his medical degree and doctor of philosophy from the University of Melbourne (Melbourne, VIC, Australia) and subsequently completed postdoctoral fellowships in Adult Congenital Heart Disease (ACHD), Advanced Heart Failure & Heart Transplantation (Toronto General Hospital, ON, Canada), & Echocardiography (Cleveland Clinic, OH, USA). Dr. Burchill has made original contributions in the area of hormonal and genetic heart failure mechanisms, heart failure in ACHD, health care transitions for adolescents with ACHD, quality of life, and transplant outcomes in ACHD patients.
Cardiac Congenital Surgery and Short Term Mortality in the United Kingdom
Presented by Aleksander Kempny, MD
Dr. Aleksander Kempny is a Cardiologist for Adult Congenital Heart Disease at the Barts Heart Centre (formerly the Heart Hospital) in London, UK. He trained at the University Hospital in Muenster, Germany and at the Royal Brompton Hospital in London, UK. He is board certified in internal medicine, cardiology and echocardiography (ESC). His academic interest includes outcome analysis in patients with congenital heart disease as well as myocardial deformation analyses on echocardiography and MRI. Dr. Kempny’s main clinical interest includes management of patients with congenital heart disease, with particular focus on patients with coexisting pulmonary hypertension, patients with cyanotic lesions and Fontan circulation.
Anesthesia Perspective on Improving Surgical Outcomes
Bryan Maxwell, MD, MPH
Randall Hospital Portland Oregon
Bryan G. Maxwell, MD, MPH is an anesthesiologist with the Oregon Anesthesiology Group in Portland, Oregon, and is Medical Director for Cardiac Anesthesiology for Legacy Emanuel Medical Center and Randall Children’s Hospital. He is a full-time clinician and provides care for adult and pediatric cardiac populations, but has a particular interest in the care of adults with congenital heart disease (ACHD).
Hybrid Hype or Necessity? What Does a Combined Surgical/ Interventional Lab Offer in ACHD?
Thomas K. Jones, MD
University of Washington School of Medicine
A Professor of Pediatrics and Adjunct Professor of Medicine at the University of Washington School of Medicine and the Director of the Cardiac Catheterization Laboratories at Seattle Children’s Hospital. Dr. Jones is a graduate of the Jefferson Medical College in Philadelphia. After completing his pediatrics residency at the University of Washington and his pediatric cardiology fellowship training at the University of Colorado and the Denver Children’s Hospital, Dr. Jones returned to Seattle where he spent the first 8 years of his career in private practice. In 1991 Dr. Jones helped create the Children’s Heart Center at the Seattle Children’s Hospital. In the same year he joined the academic faculty of the University of Washington and became the first Director of the Cardiac Catheterization Laboratories at the Seattle Children’s Hospital.
Dr. Jones’ lifelong work has focused on congenital and structural interventional cardiac catheterization in children and adults. He has worked to pioneer several less invasive techniques to correct congenital heart conditions. He has authored over 100 manuscripts, book chapters, and editorials and has participated as an investigator in over 30 multi-center clinical trials in the U.S. Dr. Jones collaborates with emerging technology companies to develop and test new products designed to treat congenital and structural heart conditions. His research interests are currently focused on percutaneous heart valve implantation. He continues to serve on national committees and task forces promoting clinical guidelines and practice standards for patients with congenital heart disease. He is collaborates with the FDA on novel approval pathways to improve patient access to more effective cardiovascular devices needed to treat the uncommon conditions that congenital cardiologists face every day.
What the Airline Industry Can Teach Us about Surgical Teams
The Hospital for Sick Children Toronto